logo
Products
Technologies
Applications
Services
Resources
Selection Guides
About
PacOrange Anti-human CD71 Antibody
HI160
HI160 is an anti-human monoclonal antibody that is specific for the CD71 antigen. CD71 (also known as Transferrin receptor protein 1) is a 95 kD member of the Transferrin receptor family that is located on the surface of cells such as endothelial cells and stem cells. In certain organisms, CD71 is a positive regulator of isotype switching, is involved in the positive regulation of T cell proliferation and acts to positively regulate B cell proliferation. From a research standpoint, it is of biological interest due to its association with important macromolecules/ligands such as Transferrin. CD71 is a fairly uncommon antibody target, with a little more than 4000 publications in the last decade. Even still, CD71 is commonly used in flow cytometry applications as a phenotypic marker for differentiation of cell types, especially in the study of immunology. This antibody was purified through affinity chromatography and conjugated to PacOrange (ex/em = 400/551 nm). It is compatible with the 405 nm laser and 525/50 nm bandpass filter (for example, as in the BD FACSymphony™ A5).
product image
product image
CatalogSize
Price
Quantity
107101K0100 tests
Price
107101K1500 tests
Price
 
Antibody properties

Other namesT9; Transferrin receptor; TFRC
CloneHI160
Hostmouse
Isotypemouse IgG2b
Reactivityhuman
ApplicationFlow Cytometry (FACS); Fluorescence Imaging
Spectral properties

Correction factor (280 nm)0.6
Extinction coefficient (cm -1 M -1)
25000
Excitation (nm)400
Emission (nm)551
Storage, safety and handling

H-phraseH303, H313, H333
Hazard symbolXN
Intended useResearch Use Only (RUO)
R-phraseR20, R21, R22
Contact us

Telephone
Fax
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
Technical SupportContact us
Request quotationRequest
Purchase orderSend to sales@aatbio.com
ShippingStandard overnight for United States, inquire for international
Page updated on September 20, 2025